China Liver Cancer Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2024 Edition).
Zhou Jian, Sun Huichuan, Wang Zheng, Cong Wenming, Zeng Mengsu, Zhou Weiping, Liu Lianxin, Wen Tianfu, Kuang Ming, Zhang Bixiang, Tao Kaishan, Han Guohong, Yan Zhiping, Wang Maoqiang, Liu Ruibao, Guo Jinhe, Zeng Zhaochong, Liang Ping, Ren Zhenggang, Hou Jinlin, Zhang Yanqiao, Liu Xiufeng, Pan Hongming, Bi Feng, Liang Changhong, Chen Min, Yan Fuhua, Xu Huixiong, Xie Xiaoyan, Ju Shenghong, Ji Yuan, Yun Jingping, Li Zengshan, Bai Xueli, Cai Dingfang, Chen Weixia, Chen Yajin, Chen Yongjun, Cheng Wenwu, Cheng Shuqun, Dai Zhi, Dai Chaoliu, Gao Qiang, Guo Rongping, Guo Wengzhi, Guo Yabing, Hua Baojin, Huang Xiaowu, Jiang Hanyu, Jia Weidong, Li Qiu, Li Tao, Li Xiangcheng, Li Xun, Li Yaming, Li Yexiong, Liang Jun, Liang Xiao, Ling Changquan, Liu Hui, Liu Tianshu, Lu Shichun, Lv Guoyue, Mao Yilei, Meng Zhiqiang, Peng Tao, Ren Weixin, Shi Guoming, Shi Hongcheng, Shi Ming, Song Tianqiang, Tan Guang, Wang Jianhua, Wang Kui, Wang Lu, Wang Wentao, Wang Xiaoying, Wang Zhiming, Xiang Bangde, Xia Jun, Xing Baocai, Xu Jianming, Xu Jun, Yang Jianyong, Yang Xinrong, Yang Yefa, Yang Yunke, Yao Xiaohong, Yin Zhenyu, Yuan Zhengang, Zeng Yongyi, Zeng Yong, Zhang Boheng, Zhang Leida, Zhang Shuijun, Zhang Ti, Zhang Zhiwei, Zhao Ming, Zhao Yongfu, Zheng Honggang, Zhou Ledu, Zhu Jiye, Zhu Kangshun, Shi Yinghong, Liu Rong, Zhang Lan, Xiao Yongsheng, Yang Chun, Wu Zhifeng, Ding Zhengbin, Zhu Xiaodong, Tang Zheng, Huang Xiaoyong, Han Hong, Wu Hong, Chen Minshan, Wang Weilin, Li Qiang, Cai Jianqiang, Shen Feng, Cai Xiujun, Qin Shukui, Teng Gaojun, Fan Jia
СтатьяПеревод пока не подготовлен
Аннотация
Hepatocellular carcinoma (HCC), which accounts for approximately 75-85% of primary liver cancers, ranks 4th in newly diagnosed cases among various types of cancer in China, and is the 2nd leading cause of cancer-related mortality, thereby posing a significant threat to the life and health of the Chinese population. Since the publication of the "Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China" in June 2017, which were updated by the China's National Health Commission in December 2019 and December 2021, additional high-quality evidence from researchers worldwide regarding the diagnosis, staging, and treatment of HCC has emerged, necessitating another update to the guidelines. The new edition (2024 Edition) was written by more than 120 multidisciplinary experts in the field of HCC in China, which not only reflects the real-world situation in China but also may reshape the nationwide diagnosis and treatment of HCC. The new guideline aims to encourage the implementation of evidence-based practice and improve the national average 5-year survival rate for patients with HCC, as proposed in the "Healthy China 2030: A Vision for Health Care."
Для цитирования: Zhou Jian, Sun Huichuan, Wang Zheng, Cong Wenming, Zeng Mengsu, Zhou Weiping, Liu Lianxin, Wen Tianfu, Kuang Ming, Zhang Bixiang, Tao Kaishan, Han Guohong, Yan Zhiping, Wang Maoqiang, Liu Ruibao, Guo Jinhe, Zeng Zhaochong, Liang Ping, Ren Zhenggang, Hou Jinlin, Zhang Yanqiao, Liu Xiufeng, Pan Hongming, Bi Feng, Liang Changhong, Chen Min, Yan Fuhua, Xu Huixiong, Xie Xiaoyan, Ju Shenghong, Ji Yuan, Yun Jingping, Li Zengshan, Bai Xueli, Cai Dingfang, Chen Weixia, Chen Yajin, Chen Yongjun, Cheng Wenwu, Cheng Shuqun, Dai Zhi, Dai Chaoliu, Gao Qiang, Guo Rongping, Guo Wengzhi, Guo Yabing, Hua Baojin, Huang Xiaowu, Jiang Hanyu, Jia Weidong, Li Qiu, Li Tao, Li Xiangcheng, Li Xun, Li Yaming, Li Yexiong, Liang Jun, Liang Xiao, Ling Changquan, Liu Hui, Liu Tianshu, Lu Shichun, Lv Guoyue, Mao Yilei, Meng Zhiqiang, Peng Tao, Ren Weixin, Shi Guoming, Shi Hongcheng, Shi Ming, Song Tianqiang, Tan Guang, Wang Jianhua, Wang Kui, Wang Lu, Wang Wentao, Wang Xiaoying, Wang Zhiming, Xiang Bangde, Xia Jun, Xing Baocai, Xu Jianming, Xu Jun, Yang Jianyong, Yang Xinrong, Yang Yefa, Yang Yunke, Yao Xiaohong, Yin Zhenyu, Yuan Zhengang, Zeng Yongyi, Zeng Yong, Zhang Boheng, Zhang Leida, Zhang Shuijun, Zhang Ti, Zhang Zhiwei, Zhao Ming, Zhao Yongfu, Zheng Honggang, Zhou Ledu, Zhu Jiye, Zhu Kangshun, Shi Yinghong, Liu Rong, Zhang Lan, Xiao Yongsheng, Yang Chun, Wu Zhifeng, Ding Zhengbin, Zhu Xiaodong, Tang Zheng, Huang Xiaoyong, Han Hong, Wu Hong, Chen Minshan, Wang Weilin, Li Qiang, Cai Jianqiang, Shen Feng, Cai Xiujun, Qin Shukui, Teng Gaojun, Fan Jia. China Liver Cancer Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2024 Edition).. Liver cancer. 2025. DOI: 10.1159/000546574.
Подготовка и перевод публикацииОбработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.